153 related articles for article (PubMed ID: 7396316)
1. Immunoglobulin replacement therapy by slow subcutaneous infusion.
Berger M; Cupps TR; Fauci AS
Ann Intern Med; 1980 Jul; 93(1):55-6. PubMed ID: 7396316
[No Abstract] [Full Text] [Related]
2. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies.
Dams ET; van der Meer JW
Lancet; 1995 Apr; 345(8953):864. PubMed ID: 7898254
[No Abstract] [Full Text] [Related]
3. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs.
Gardulf A; Andersen V; Björkander J; Ericson D; Frøland SS; Gustafson R; Hammarström L; Jacobsen MB; Jonsson E; Möller G
Lancet; 1995 Feb; 345(8946):365-9. PubMed ID: 7845120
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin therapy: methods of delivery.
Ballow M
J Allergy Clin Immunol; 2008 Nov; 122(5):1038-9. PubMed ID: 18804269
[No Abstract] [Full Text] [Related]
5. Subcutaneous immunoglobulin loading regimens for previously untreated patients with primary antibody deficiency.
Rojavin M; Sidhu J; Pfister M; Hubsch A
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):146-8. PubMed ID: 25546799
[No Abstract] [Full Text] [Related]
6. [Substitution therapy in immunologic deficiency syndromes].
Iartsev MN; Gomes LA
Pediatriia; 1989; (12):71-6. PubMed ID: 2628915
[No Abstract] [Full Text] [Related]
7. New choices for treatment with subcutaneous immunoglobulins.
Pleguezuelo DE; Sánchez-Ramón S
Med Clin (Barc); 2017 Jan; 148(2):86-90. PubMed ID: 27919413
[No Abstract] [Full Text] [Related]
8. Immunoglobulin Replacement Therapy for Primary Immunodeficiency.
Sriaroon P; Ballow M
Immunol Allergy Clin North Am; 2015 Nov; 35(4):713-30. PubMed ID: 26454315
[TBL] [Abstract][Full Text] [Related]
9. Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies.
Canessa C; Iacopelli J; Pecoraro A; Spadaro G; Matucci A; Milito C; Vultaggio A; Agostini C; Cinetto F; Danieli MG; Gambini S; Marasco C; Trizzino A; Vacca A; De Mattia D; Martire B; Plebani A; Di Gioacchino M; Gatta A; Finocchi A; Licciardi F; Martino S; De Carli M; Moschese V; Azzari C
Int J Immunopathol Pharmacol; 2017 Mar; 30(1):73-82. PubMed ID: 27927705
[TBL] [Abstract][Full Text] [Related]
10. IgG replacement therapy, no size fits all.
Bonilla FA
Clin Immunol; 2011 May; 139(2):107-9. PubMed ID: 21420364
[No Abstract] [Full Text] [Related]
11. Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: inadequacy of current dosage practices and approaches to the problem.
Buckley RH
J Clin Immunol; 1982 Apr; 2(2 Suppl):15S-21S. PubMed ID: 6806314
[No Abstract] [Full Text] [Related]
12. [Use of intravenous and subcutaneous human immunoglobulins].
Ramus B; Benbrahim O; Chérin P
Soins; 2019 Mar; 64(833):13-18. PubMed ID: 30879622
[TBL] [Abstract][Full Text] [Related]
13. [Immunoglobulins and immune deficiency: methods of administration].
Suarez F
Rev Med Interne; 2005 Oct; 26 Spec No 1():25-8. PubMed ID: 16475260
[No Abstract] [Full Text] [Related]
14. Immunoglobulin replacement therapy in antibody deficiency syndromes: are we really doing enough?
Baumann U; Miescher S; Vonarburg C
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):83-5. PubMed ID: 25546772
[No Abstract] [Full Text] [Related]
15. Immunoglobulin replacement therapy.
Sorensen RU; Polmar SH
Ann Clin Res; 1987; 19(4):293-304. PubMed ID: 3314655
[No Abstract] [Full Text] [Related]
16. [Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].
Pac M
Pol Merkur Lekarski; 2011 Jun; 30(180):413-6. PubMed ID: 21751550
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.
Shapiro RS
Pediatr Allergy Immunol; 2013 Feb; 24(1):49-53. PubMed ID: 23331529
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous immunoglobulin replacement in primary immunodeficiencies.
Berger M
Clin Immunol; 2004 Jul; 112(1):1-7. PubMed ID: 15207776
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter study.
Vultaggio A; Azzari C; Milito C; Finocchi A; Toppino C; Spadaro G; Trizzino A; Baldassarre M; Paganelli R; Moschese V; Soresina A; Matucci A
Clin Drug Investig; 2015 Mar; 35(3):179-85. PubMed ID: 25672929
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin: a review.
Eibl MM; Wedgwood RJ
Immunodefic Rev; 1989; 1 Suppl():1-42. PubMed ID: 2698646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
